Abstract
The genus Aconitum (family—Ranunculaceae) accounts for approximately 400 species worldwide, of which some are considered medicinally very relevant. Many species have been reported to possess significant pharmacological properties and high therapeutic index for curing various diseases. Traditionally, Aconitum species have been used for the treatment of different human ailments, especially, neuronal disorders, pain and inflammation, kidney related disorders, rheumatism, diabetes, hysteria and cardiac depression. These medicinal properties have been attributed to various classes of secondary metabolites found in different Aconitum species. Among them, C19 and C20-diterpenoid alkaloids are the most dynamic group of compounds, comprising of more than 450 alkaloids in various species across the genus. However, further detailed phytochemical investigations of Aconitum species could provide new therapeutic natural products of Aconitum source that could be employed in health and medicine. The present study aims to frame a well structured portfolio to provide contemporary insights of the genus Aconitum. The retrospection of all the available information on Aconitum associated with its various attributes was carried out by searching different electronic databases viz. Elsevier, PubMed, Web of Science, Scifinder, ScienceDirect, ResearchGate, Google Scholar, Bio One, PLOS. The review summarizes the findings on traditional uses, phytochemistry, and pharmacology of various species of the genus. The toxicology and safety of Aconitum species for human consumption as herbal drugs has also been discussed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.